Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.
Saved in:
| Title: | Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer. |
|---|---|
| Authors: | Li, Guiling1 (AUTHOR), Li, Xiaofan1,2 (AUTHOR), Yin, Rutie3 (AUTHOR), Feng, Mei4 (AUTHOR), Zuo, Jing5 (AUTHOR), Wei, Shuqing6 (AUTHOR), Kang, Shan7 (AUTHOR), Sun, Hongmei8 (AUTHOR), Li, Xiumin9 (AUTHOR), Wang, Yili10 (AUTHOR), Zhang, Yunyan11 (AUTHOR), Sun, Li12 (AUTHOR), Lin, Daren13 (AUTHOR), Ruan, Xiaohong13 (AUTHOR), Zhu, Zhitu14 (AUTHOR), Jiang, Kui15 (AUTHOR), Liu, Hu16 (AUTHOR), Wang, Wei17 (AUTHOR), Hao, Deshun18 (AUTHOR), Chen, Ying18 (AUTHOR) |
| Source: | Gynecologic Oncology. Dec2024, Vol. 191, p165-171. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 181540972 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Li%2C+Guiling%22">Li, Guiling</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiaofan%22">Li, Xiaofan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yin%2C+Rutie%22">Yin, Rutie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+Mei%22">Feng, Mei</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zuo%2C+Jing%22">Zuo, Jing</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wei%2C+Shuqing%22">Wei, Shuqing</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang%2C+Shan%22">Kang, Shan</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Hongmei%22">Sun, Hongmei</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiumin%22">Li, Xiumin</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yili%22">Wang, Yili</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yunyan%22">Zhang, Yunyan</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Li%22">Sun, Li</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Daren%22">Lin, Daren</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruan%2C+Xiaohong%22">Ruan, Xiaohong</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Zhitu%22">Zhu, Zhitu</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Kui%22">Jiang, Kui</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Hu%22">Liu, Hu</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Wei%22">Wang, Wei</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hao%2C+Deshun%22">Hao, Deshun</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Ying%22">Chen, Ying</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Dec2024, Vol. 191, p165-171. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=181540972 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2024.10.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 165 Titles: – TitleFull: Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li, Guiling – PersonEntity: Name: NameFull: Li, Xiaofan – PersonEntity: Name: NameFull: Yin, Rutie – PersonEntity: Name: NameFull: Feng, Mei – PersonEntity: Name: NameFull: Zuo, Jing – PersonEntity: Name: NameFull: Wei, Shuqing – PersonEntity: Name: NameFull: Kang, Shan – PersonEntity: Name: NameFull: Sun, Hongmei – PersonEntity: Name: NameFull: Li, Xiumin – PersonEntity: Name: NameFull: Wang, Yili – PersonEntity: Name: NameFull: Zhang, Yunyan – PersonEntity: Name: NameFull: Sun, Li – PersonEntity: Name: NameFull: Lin, Daren – PersonEntity: Name: NameFull: Ruan, Xiaohong – PersonEntity: Name: NameFull: Zhu, Zhitu – PersonEntity: Name: NameFull: Jiang, Kui – PersonEntity: Name: NameFull: Liu, Hu – PersonEntity: Name: NameFull: Wang, Wei – PersonEntity: Name: NameFull: Hao, Deshun – PersonEntity: Name: NameFull: Chen, Ying IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00908258 Numbering: – Type: volume Value: 191 Titles: – TitleFull: Gynecologic Oncology Type: main |
| ResultId | 1 |